Current U.S. Student

United States citizens who are currently enrolled in undergraduate or graduate degree programs are eligible to apply. All applicants enrolled in U.S institutions must apply through their home campuses. Find the Fulbright Program Adviser on your campus.

If you are an undergraduate student, you are eligible to apply in the fall of your senior year.  If you are a graduate student, you are eligible as long as you will not have a PhD degree by the application deadline.

U.S. Citizen but not a Student

If you are a U.S. citizen, hold a bachelor’s degree, and do not have a PhD degree, then you are eligible to apply. Non-enrolled applicant should have relatively limited professional experience in the fields (typically 7 years or less) in which they are applying. Candidates with more experience should consider applying for the Fulbright Scholar Program.
Please review the program summary for the country where you would like to apply.


The Fulbright U.S. Student Program welcomes applications in the creative and performing arts. Arts candidates for the U.S. Student Program should have relatively limited professional experience in the fields (typically 5 years or less) in which they are applying. Artists with more experience should consider applying for the Fulbright Scholar Program.

Creative & Performing Arts projects fall under the Study/Research grant category and are available in all countries where Study/Research grants are offered. 



U.S. Professor

If you are a U.S. citizen and a professor at a U.S. institution and are interested in applying for a Fulbright Scholar Award, you will need to apply through CIES.

Non U.S. Citizens

If you are a non-U.S. citizen interested in applying for a Fulbright Award to the United States, you will need to apply through the Fulbright Commission or U.S. Embassy in your home country. Find out more information on the Fulbright Visiting Scholar or Student Program.


< Back to country

3 Fulbright-Fogarty Public Health Fellowship Awards

Accepted Degree Levels
Grant Period
9 Months
Award Profile

The Fulbright-Fogarty fellowship in Uganda offers U.S. undergraduate and post-graduate students in the health sciences practical experience designing and conducting clinical research in Uganda.  

Affiliation: Makerere College of Health Sciences; Walimu; Yale University

Background: The Makerere University College of Health Sciences and Yale University host a long-standing collaboration in lung disease research. The program focuses on tuberculosis (TB) and other pulmonary complications of HIV, with an emphasis on diagnosis and active case finding of TB. These sites provide research training opportunities for US doctoral students in the area of TB and other pulmonary complications of HIV.

Site: Kimpala, Uganda

Focus: Lung Health


Ongoing Projects

  •  Mobile Health for Implementation of Home-based TB Contact Investigation in Uganda 
  •  International Research Training on TB and Other Pulmonary Complications of HIV 
  •  Pediatric TB Evaluation and Management Guideline Implementation Support
  • Severe Illness Management Support
  • Practical Approach to Lung Health

Additional Resources:  

U.S. Partner:  Global Health Equity Scholars Fellowship (GHES)

Lead Mentor: J. Lucian (Luke) Davis, MD, MAS –

Site Contact: Achilles Katamba, MBChB, PhD –

Affiliation: Makerere University, Infectious Diseases Research Collaboration (IDRC)

Background: Established in 1998 by Drs. M. Kamya (MU) and P. Rosenthal (UCSF), IDRC is a research collaboration between Makerere University and University of California, San Francisco. The collaboration encompasses a broad range of research in infectious diseases, including malaria, HIV, and tuberculosis (TB), using molecular, clinical, epidemiological, and implementation science approaches.

Important projects include:

  • Sustainable East Africa Research on Community Health (SEARCH), an NIH-funded study in Uganda and Kenya studying optimal provision of care for HIV and other medical problems.
  • Program for Resistance, Immunology, Surveillance, and Modeling of Malaria in Uganda (PRISM), an NIH Center of Excellence for Malaria Research with broad research centered on surveillance for malaria in the context of changing control practices in Uganda.
  • Prevention of Malaria and HIV Disease in Tororo, a set of randomized trials evaluating optimal malaria control practices for pregnant women and their children.

Other major programs study immune responses to malaria infection, antimalarial drug resistance, the pharmacokinetics and pharmacodynamics of antimalarial therapies, antimalarial treatment efficacy, antiretroviral therapy initiation, HIV-associated pneumonia, and TB transmission. A FIC-funded program for training of Ugandan scientists in malaria research has been in place since 2000 and has trained over 60 junior scientists.



U.S. Partner:  GloCal Health Fellowship

Site Contact: Catherine

Affiliation: Makerere Lung Institute (MLI)

Background: The mission of the Makerere Lung Institute (MLI) is to integrate disease prevention, clinical care, and training to combat lung disease in Uganda and across sub-Saharan Africa. MLI was founded in 2015 under the directorship of Dr. Bruce Kirenga, Associate Professor of Medicine at Makerere University. Investigators at the Lung Institute have been instrumental in publishing initial prevalence estimates for a range of respiratory diseases in Uganda. The collaboration between Johns Hopkins University and the Makerere Lung Institute is further supported by a Global Established Multidisciplinary Site (GEMS) by the Johns Hopkins Center for Global Health.

Lung Function in Nakaseke and Uganda (LiNK) Cohort: The LiNK study is a longitudinal cohort aimed at assessing the role of urbanization in lung function decline in Uganda. The primary aim of the study was to examine the differences in prevalence of CRDs and attributable risk factors in urban and rural Uganda. The LiNK Study investigators aim to conduct follow up at 3 years and 5 years as part of longitudinal analysis of risk factors for lung function decline in this setting. The LiNK Cohort Study represents a partnership between Johns Hopkins University and Makerere Lung Institute in Uganda. The study was funded through the Fogarty International Center and COPD Foundation.

Global Excellence in COPD Outcomes (GECo) Study: Self-management of chronic respiratory illness has the potential to bring relief and improved quality of life to people who are not able to easily seek care at health facilities. The GECO cohort aims to first assess the diagnostic accuracy of a short COPD case-finding questionnaire before determining the clinical effectiveness, cost-effectiveness, and feasibility of implementation of a self-directed COPD Action Plan in three varying LMIC settings.

The cohort will include an age- and sex-stratified random sample of approximately 12,000 adults age ≥40 years in Bhaktapur, Nepal; Lima, Peru; and Nakaseke, Uganda, each of which have been found to have a high prevalence of COPD. Each participant will have basic demographic information collected as well as anthropological measurements and spirometry testing. Those with COPD will be administered additional questionnaires, such as the LFQ, CAPTURE, MRC Dyspnea Scale, SGRQ, and EQ-5D. Based on current prevalence estimates, we anticipate recruiting 1,200 adults with COPD into the later stages of the study. Those who are enrolled will receive standardized COPD self-management education by trained Community Health Workers before being randomized into Action Plan or Standard Care groups. These groups will be followed up for one year with additional survey data collected.

U.S. Partner:

Affiliation: Infectious Diseases Institute (IDI)

Background: The IDI, located in Kampala, is a United Nations-recognized African Network for Drugs and Diagnostics Innovation (ANDI) Research Center of Excellence in infectious disease, as well as a key institutional research member of the Makerere University Medical Educational Partnership Initiative in Uganda. The IDI site focuses on HIV/TB and related conditions, and malaria. IDI has collaborated with faculty from UCSF since its inception in 2004 and participated in large international trials in HIV treatment and prevention, malaria, tuberculosis (TB), hepatitis B and other infectious diseases. IDI has an annual budget of ~$20M, including National Institutes of Health and other international donors. By June 2015, IDI's program included 45 active research studies, consisting of 12 clinical trials, 18 observational studies, and 15 research capacity-building projects. IDI's research facility, the Translational Research Laboratory, is 800 square feet of newly renovated space at Makerere University. The Lab employs five full-time staff and supports six key areas of investigation: immunology, virology, molecular biology, microbiology, pharmacokinetics, and point of care diagnostics.


U.S. Partner:  GloCal Health Fellowship

Site Contact: Dr. Andrew Kambugu

Affiliation: Infectious Diseases Institute (IDI)

The IDI was founded in 2004 in Kampala, Uganda with a tricare mission to provide clinical care, train health care workers, and perform clinical research. The IDI employs more than 1000 staff and works in more than 70% of the districts in the country. Although much of the research at the IDI centers around HIV and related opportunistic infection, there has been a notable expansion of activities to include global health security (acute febrile illness and gonococcal surveillance), non-communicable diseases, diagnostics and translational laboratory research with more than 90 projects currently running. ( ).

Observational cohort research in collaboration with the Outreach Programme– the IDI and all the routinely collected data from HIV programs nationwide cover more than 150,000 persons living with HIV. In addition, in collaboration with the Ministry of Health and the National Tuberculosis and Leprosy Programme, tuberculosis data can also be used to answer operational research questions.

Implementation Science – MENTORS – tuberculosis case finding and treatment, SHARE – Sharing HIV/AIDS Responsibilities and Efforts – a task sharing projects, and HEARD (Health evaluation and applied research development).

Diagnostic development and evaluation particularly of point-of care test around acute febrile illness, sexually transmitted infections, and TB and their patient-centered impact.

Site Contact:

U.S. Partner: UJMT Fogarty Global Health Fellowship


  • Makerere University Infectious Diseases Institute (Kampala)
  • Global Health Uganda (Kampala)
  • Mbarara University of Science and Technology (Mbarara)

Background: The University of Minnesota has a long-standing research relationship with multiple colleges at Makerere University (Infectious Disease Institute, College of Health Sciences, School of Medicine, and the College of Veterinary Medicine, Animal Resources, and Biosecurity) starting in 2005 and with Mbarara University starting in 2010 regarding neuro-infectious disease research. The University of Minnesota has enabled training for 7 PhDs and 13 master’s Ugandan trainees through nested projects of NIH-sponsored clinical research. Since 2012, 20 Fogarty Scholars and Fellows have been trained in this capacity through 1-year global health fellowships (1 at MUST, 19 at Makerere). Additionally, three Ugandan principal investigators have obtained independent NIH funding.

The University of Minnesota has strong resources to support research fellows through an extensive network of researchers at all three institutions committed to advancing research training.

Project descriptions:

  • HIV and Cryptococcal Meningitis
  • Epidemiology and surveillance systems for infectious disease and zoonotic infection
  • Mobile health interventions (women’s health and HIV)
  • Immunology
  • Neuropsychology
  • Nutrition (primarily pediatric) and infectious disease
  • Vaccine research
  • Surgery


US Partner: University of Minnesota

Grant Period

9 Months

Grants are for 9-10 months during the period of August 1 - June 30.

Pre-Departure Orientation


Grantees will be required to participate in a Pre-Departure Orientation with NIH in July 2020.

Candidate Profile

Candidates should be self-motivated, flexible and adaptable. They should be ready to embrace a different culture from the one to which they are accustomed. Candidates must fall under one of the following categories: Post-third year medical school;; Ph.D. students in health sciences (post-Master’s-level), must be enrolled in an accredited doctoral level program (MD, PhD or equivalent).

Accepted Degree Levels


Foreign Language Proficiency

Not Required

Although English is the official language, knowledge of the local language where one will be conducting research is advantageous. 

Fulbright Proposal Types

Independent Study/Research: Yes

Graduate Degree Enrollment: No


Applicants are required to obtain a letter of support from the site contact. 

When emailing project contacts, please include both contacts and attach a current CV and a concise statement (less than 500 words) about your interest in the program (especially your primary research interest).  

Special Application Instructions

Select "Fulbright-Fogarty" for Award Type in the application.  

All Fulbright-Fogarty applicants pursuing a placement in Uganda should select “Public Health” as the Field of Study in the Fulbright application. 

Specific Considerations

Rebel and bandit activity in the areas along the Sudanese border in northern Uganda and in the Democratic Republic of Congo (DRC) along the western border have in a few instances made these areas unstable and insecure. Caution should be exercised when carrying out research near these borders. For the latest security information, Americans carrying out research abroad should regularly monitor the State Department’s website, where the current Travel Warnings, Travel Alerts, and Worldwide Caution can be found.

Health Considerations

Medical facilities in Uganda, including in Kampala, are limited and not equipped to handle most emergencies, especially those requiring surgery. Outside of Kampala, hospitals are scarce and offer only basic services. Equipment and medicines are often in short supply or unavailable. Researchers should carry their own supplies of prescription drugs and preventive medicines. Malaria is prevalent in Uganda. For additional information on malaria, including protective measures, see the Centers for Disease Control (CDC) Travelers Health website. Information on vaccinations and other health precautions may be obtained from the CDC’s website. For information on outbreaks of infectious diseases abroad consult the World Health Organization (WHO) website. Further health information is available here.


Dependent support is available.

Fulbright Commission/U.S. Embassy Website

Fulbright Commission/U.S. Embassy Contact

Dorothy Ngalombi / Niles Cole